Viewing Study NCT06682806


Ignite Creation Date: 2025-12-26 @ 2:39 PM
Ignite Modification Date: 2026-03-01 @ 5:00 PM
Study NCT ID: NCT06682806
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-28
First Post: 2024-10-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Sponsor: Prelude Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module